This announcement is a separate document:
恒瑞医药：恒瑞医药2022年半年度报告摘要
Hengrui Pharmaceutical: Summary of Hengrui Pharmaceutical's 2022 semi-annual report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.